Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 4 Results

Title
Intervention Indication Therapeutic Area Year Actions
Dupilumab for treating eosinophilic oesophagitis in people aged 12 years and older Dupilumab (Dupixent; REGN-668; SAR-231893; REGN668; SAR231893) Eosinophilic oesophagitis Gastroenterology , Immunology 2022 View  |  Download
Dupilumab for eosinophilic oesophagitis in paediatric patients Dupilumab (Dupixent; REGN-668; SAR-231893; REGN668; SAR231893) Eosinophilic oesophagitis Gastroenterology , Immunology 2023 View  |  Download
Budesonide suspension for treating eosinophilic oesophagitis in children and adolescents Budesonide orodispersible (Jorveza) Eosinophilic oesophagitis Gastroenterology , Immunology 2023 View  |  Download
Benralizumab for treating eosinophilic oesophagitis in people aged 12-65 years Benralizumab (Fasenra; MEDI563) Eosinophilic oesophagitis Gastroenterology 2022 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications